Topics

“He said things about it publicly that he wasn’t supposed to,” Dexcom’s CEO told ⁦@erbrod⁩, in reference to the Verily CEO’s #jpm20 presentation on the two companies’ CGM collaboration. story: https://www.statnews.com/2020/01/16/verily-d

11:55 EST 16 Jan 2020 | STAT

“He said things about it publicly that he wasn’t supposed to,” Dexcom’s CEO told ⁦ ⁩, in reference to the Verily CEO’s presentation on the two companies’ CGM collaboration. 👀 story: https://www.statnews.com/2020/01/16/verily-dexcom-tango-at-jpm-over-new-glucose-monitor/ …

Original Article: “He said things about it publicly that he wasn’t supposed to,” Dexcom’s CEO told ⁦@erbrod⁩, in reference to the Verily CEO’s #jpm20 presentation on the two companies’ CGM collaboration. story: https://www.statnews.com/2020/01/16/verily-d

NEXT ARTICLE

More From BioPortfolio on "“He said things about it publicly that he wasn’t supposed to,” Dexcom’s CEO told ⁦@erbrod⁩, in reference to the Verily CEO’s #jpm20 presentation on the two companies’ CGM collaboration. story: https://www.statnews.com/2020/01/16/verily-d"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...